505 related articles for article (PubMed ID: 23810254)
1. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model.
Weber B; Dijkman PE; Scherman J; Sanders B; Emmert MY; Grünenfelder J; Verbeek R; Bracher M; Black M; Franz T; Kortsmit J; Modregger P; Peter S; Stampanoni M; Robert J; Kehl D; van Doeselaar M; Schweiger M; Brokopp CE; Wälchli T; Falk V; Zilla P; Driessen-Mol A; Baaijens FP; Hoerstrup SP
Biomaterials; 2013 Oct; 34(30):7269-80. PubMed ID: 23810254
[TBL] [Abstract][Full Text] [Related]
2. Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts.
Dijkman PE; Driessen-Mol A; Frese L; Hoerstrup SP; Baaijens FP
Biomaterials; 2012 Jun; 33(18):4545-54. PubMed ID: 22465337
[TBL] [Abstract][Full Text] [Related]
3. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
[TBL] [Abstract][Full Text] [Related]
4. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
5. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates.
Weber B; Scherman J; Emmert MY; Gruenenfelder J; Verbeek R; Bracher M; Black M; Kortsmit J; Franz T; Schoenauer R; Baumgartner L; Brokopp C; Agarkova I; Wolint P; Zund G; Falk V; Zilla P; Hoerstrup SP
Eur Heart J; 2011 Nov; 32(22):2830-40. PubMed ID: 21415068
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter implantation of homologous "off-the-shelf" tissue-engineered heart valves with self-repair capacity: long-term functionality and rapid in vivo remodeling in sheep.
Driessen-Mol A; Emmert MY; Dijkman PE; Frese L; Sanders B; Weber B; Cesarovic N; Sidler M; Leenders J; Jenni R; Grünenfelder J; Falk V; Baaijens FPT; Hoerstrup SP
J Am Coll Cardiol; 2014 Apr; 63(13):1320-1329. PubMed ID: 24361320
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
[TBL] [Abstract][Full Text] [Related]
8. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
Weber B; Zeisberger SM; Hoerstrup SP
Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
[TBL] [Abstract][Full Text] [Related]
9. Living autologous heart valves engineered from human prenatally harvested progenitors.
Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP
Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561
[TBL] [Abstract][Full Text] [Related]
10. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
[TBL] [Abstract][Full Text] [Related]
11. Challenges in developing a reseeded, tissue-engineered aortic valve prosthesis.
Hof A; Raschke S; Baier K; Nehrenheim L; Selig JI; Schomaker M; Lichtenberg A; Meyer H; Akhyari P
Eur J Cardiothorac Surg; 2016 Sep; 50(3):446-55. PubMed ID: 27084195
[TBL] [Abstract][Full Text] [Related]
12. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
[TBL] [Abstract][Full Text] [Related]
13. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model.
Flanagan TC; Sachweh JS; Frese J; Schnöring H; Gronloh N; Koch S; Tolba RH; Schmitz-Rode T; Jockenhoevel S
Tissue Eng Part A; 2009 Oct; 15(10):2965-76. PubMed ID: 19320544
[TBL] [Abstract][Full Text] [Related]
14. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds.
Iop L; Renier V; Naso F; Piccoli M; Bonetti A; Gandaglia A; Pozzobon M; Paolin A; Ortolani F; Marchini M; Spina M; De Coppi P; Sartore S; Gerosa G
Biomaterials; 2009 Sep; 30(25):4104-16. PubMed ID: 19481252
[TBL] [Abstract][Full Text] [Related]
15. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
16. Trans-apical versus surgical implantation of autologous ovine tissue-engineered heart valves.
Dijkman PE; Driessen-Mol A; de Heer LM; Kluin J; van Herwerden LA; Odermatt B; Baaijens FP; Hoerstrup SP
J Heart Valve Dis; 2012 Sep; 21(5):670-8. PubMed ID: 23167234
[TBL] [Abstract][Full Text] [Related]
17. Improved Geometry of Decellularized Tissue Engineered Heart Valves to Prevent Leaflet Retraction.
Sanders B; Loerakker S; Fioretta ES; Bax DJ; Driessen-Mol A; Hoerstrup SP; Baaijens FP
Ann Biomed Eng; 2016 Apr; 44(4):1061-71. PubMed ID: 26183964
[TBL] [Abstract][Full Text] [Related]
18. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model].
Leyh R; Wilhelmi M; Haverich A; Mertsching H
Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763
[TBL] [Abstract][Full Text] [Related]
19. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells.
Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G
Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701
[TBL] [Abstract][Full Text] [Related]
20. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions.
Lichtenberg A; Tudorache I; Cebotari S; Suprunov M; Tudorache G; Goerler H; Park JK; Hilfiker-Kleiner D; Ringes-Lichtenberg S; Karck M; Brandes G; Hilfiker A; Haverich A
Circulation; 2006 Jul; 114(1 Suppl):I559-65. PubMed ID: 16820637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
